Revvity (RVTY) Revenue & Revenue Breakdown

Overview ForecastFinancials Chart Transcripts

Revvity Revenue Highlights

Latest Revenue (Y)

$2.86B

Latest Revenue (Q)

$698.95M

Main Segment (Y)

Life Sciences

Main Geography (Y)

Other International

Revvity Revenue by Period

Revvity Revenue by Year

Date	Revenue	Change
2025-12-28	$2.86B	3.67%
2024-12-29	$2.76B	0.16%
2023-12-31	$2.75B	-16.95%
2022-12-31	$3.31B	-13.48%
2021-12-31	$3.83B	1.19%
2020-12-31	$3.78B	31.18%
2019-12-31	$2.88B	3.80%
2018-12-31	$2.78B	23.08%
2017-12-31	$2.26B	6.69%
2016-12-31	$2.12B	0.51%
2015-12-31	$2.10B	-5.92%
2014-12-31	$2.24B	3.28%
2013-12-31	$2.17B	2.41%
2012-12-31	$2.12B	10.09%
2011-12-31	$1.92B	12.73%
2010-12-31	$1.70B	9.90%
2009-12-31	$1.55B	-20.88%
2008-12-31	$1.96B	9.66%
2007-12-31	$1.79B	15.58%
2006-12-31	$1.55B	4.92%
2005-12-31	$1.47B	3.13%
2004-12-31	$1.43B	-6.91%
2003-12-31	$1.54B	2.01%
2002-12-31	$1.50B	13.15%
2001-12-31	$1.33B	-21.54%
2000-12-31	$1.70B	24.37%
1999-12-31	$1.36B	-3.18%
1998-12-31	$1.41B	-3.62%
1997-12-31	$1.46B	2.35%
1996-12-31	$1.43B	0.54%
1995-12-31	$1.42B	6.53%
1994-12-31	$1.33B	-50.61%
1993-12-31	$2.70B	-

Revvity generated $2.86B in revenue during NA 2025, up 3.67% compared to the previous quarter, and up 75.50% compared to the same period a year ago.

Revvity Revenue by Quarter

Date	Revenue	Change
2025-09-28	$698.95M	-2.96%
2025-06-29	$720.28M	8.35%
2025-03-30	$664.76M	-8.86%
2024-12-29	$729.37M	6.63%
2024-09-29	$684.05M	-1.10%
2024-06-30	$691.68M	6.43%
2024-03-31	$649.92M	-6.61%
2023-12-31	$695.90M	3.75%
2023-09-30	$670.74M	-5.41%
2023-06-30	$709.07M	5.07%
2023-04-02	$674.87M	-8.95%
2022-12-31	$741.21M	4.13%
2022-10-02	$711.80M	-20.53%
2022-06-30	$895.64M	-7.01%
2022-03-31	$963.16M	-6.30%
2021-12-31	$1.03B	19.34%
2021-09-30	$861.32M	-29.89%
2021-06-30	$1.23B	-6.06%
2021-03-31	$1.31B	-3.46%
2020-12-31	$1.35B	40.52%
2020-09-30	$964.02M	18.76%
2020-06-30	$811.72M	24.42%
2020-03-31	$652.40M	-19.01%
2019-12-31	$805.50M	13.94%
2019-09-30	$706.92M	-2.16%
2019-06-30	$722.52M	11.37%
2019-03-31	$648.74M	-14.23%
2018-12-31	$756.35M	12.17%
2018-09-30	$674.31M	-4.13%
2018-06-30	$703.36M	9.22%
2018-03-31	$643.97M	0.37%
2017-12-31	$641.63M	15.76%
2017-09-30	$554.27M	1.34%
2017-06-30	$546.96M	6.39%
2017-03-31	$514.12M	-9.29%
2016-12-31	$566.77M	3.41%
2016-09-30	$548.05M	-4.30%
2016-06-30	$572.67M	6.31%
2016-03-31	$538.68M	-11.42%
2015-12-31	$608.12M	7.93%
2015-09-30	$563.44M	-0.08%
2015-06-30	$563.91M	7.02%
2015-03-31	$526.90M	-13.39%
2014-12-31	$608.39M	12.24%
2014-09-30	$542.05M	-2.54%
2014-06-30	$556.17M	4.56%
2014-03-31	$531.90M	-10.35%
2013-12-31	$593.28M	13.16%
2013-09-30	$524.28M	-3.50%
2013-06-30	$543.30M	7.50%
2013-03-31	$505.38M	-11.79%
2012-12-31	$572.92M	12.42%
2012-09-30	$509.60M	-2.34%
2012-06-30	$521.79M	2.13%
2012-03-31	$510.89M	-5.42%
2011-12-31	$540.19M	19.05%
2011-09-30	$453.74M	-5.37%
2011-06-30	$479.49M	7.06%
2011-03-31	$447.86M	-4.70%
2010-12-31	$469.97M	12.13%
2010-09-30	$419.14M	-15.81%
2010-06-30	$497.84M	7.04%
2010-03-31	$465.09M	-8.62%
2009-12-31	$508.99M	16.46%
2009-09-30	$437.06M	0.57%
2009-06-30	$434.57M	0.70%
2009-03-31	$431.57M	2.42%
2008-12-31	$421.37M	-16.58%
2008-09-30	$505.12M	-4.45%
2008-06-30	$528.64M	-

Revvity generated $698.95M in revenue during Q3 2025, up -2.96% compared to the previous quarter, and up 101.05% compared to the same period a year ago.

Revvity Revenue Breakdown

Revvity Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24
Life Sciences	$1.43B	$1.25B
Diagnostics	$1.42B	$1.50B

Revvity's latest annual revenue breakdown by segment (product or service), as of Dec 25: Life Sciences (50.11%), and Diagnostics (49.89%).

Quarterly Revenue by Product

Product/Service	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24
Diagnostics	$390.07M	$356.13M	$354.39M	$324.37M	$1.12B	$383.13M	-
Life Sciences	$381.99M	$342.82M	$365.90M	$340.39M	$953.22M	$300.92M	-
Product	-	-	-	-	-	-	$565.75M
Service	-	-	-	-	-	-	$84.17M

Revvity's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Diagnostics (50.52%), and Life Sciences (49.48%).

Revvity Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 25	Dec 24
CHINA	$425.06M	$450.01M
UNITED STATES	$1.13B	$1.10B
UNITED KINGDOM	$126.85M	$112.88M
Other International	$2.73B	$2.75B
GERMANY	$177.66M	-

Revvity's latest annual revenue breakdown by geography, as of Dec 25: Other International (59.53%), UNITED STATES (24.56%), CHINA (9.27%), GERMANY (3.87%), and UNITED KINGDOM (2.77%).

Quarterly Revenue by Country

Country	Sep 25	Jun 25	Mar 25	Sep 24	Mar 24
Asia	$189.28M	$193.07M	$178.34M	$199.69M	$177.00M
Europe	$202.40M	$203.63M	$181.79M	$182.04M	$178.56M
Americas	$307.28M	$323.58M	$304.63M	$302.32M	$294.35M

Revvity's latest quarterly revenue breakdown by geography, as of Sep 25: Americas (43.96%), Europe (28.96%), and Asia (27.08%).

Revvity Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
RDY	Dr. Reddy's Laboratories	$279.16B	-
SOLV	Solventum	$8.32B	$2.10B
ICLR	ICON Public	$8.12B	$2.09B
ENSG	Ensign Group	$5.06B	$1.30B
ALGN	Align	$4.03B	$995.69M
CRL	Charles River Laboratories	$4.02B	$1.00B
EXAS	Exact Sciences	$3.25B	$850.74M
RVTY	Revvity	$2.86B	$698.95M
HIMS	Hims & Hers Health	$2.35B	$598.98M
QGEN	Qiagen	$1.97B	$458.80M
GH	Guardant Health	$982.02M	$265.20M

RVTY Revenue FAQ

What is Revvity’s yearly revenue?

Revvity's yearly revenue for 2025 was $2.86B, representing an increase of 3.67% compared to 2024. The company's yearly revenue for 2024 was $2.76B, representing an increase of 0.16% compared to 2023. RVTY's yearly revenue for 2023 was $2.75B, representing a decrease of -16.95% compared to 2022.

What is Revvity’s quarterly revenue?

Revvity's quarterly revenue for Q3 2025 was $698.95M, a -2.96% decrease from the previous quarter (Q2 2025), and a 2.18% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $720.28M, a 8.35% increase from the previous quarter (Q1 2025), and a 4.13% increase year-over-year (Q2 2024). RVTY's quarterly revenue for Q1 2025 was $664.76M, a -8.86% decrease from the previous quarter (Q4 2024), and a 2.28% increase year-over-year (Q1 2024).

What is Revvity’s revenue growth rate?

Revvity's revenue growth rate for the last 3 years (2023-2025) was 3.83%, and for the last 5 years (2021-2025) was -25.39%.

What are Revvity’s revenue streams?

Revvity's revenue streams in c 25 are Life Sciences, and Diagnostics. Life Sciences generated $1.43B in revenue, accounting 50.11% of the company's total revenue, up 14.11% year-over-year. Diagnostics generated $1.42B in revenue, accounting 49.89% of the company's total revenue, down -5.06% year-over-year.

What is Revvity’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Revvity was Life Sciences. This segment made a revenue of $1.43B, representing 50.11% of the company's total revenue.